Paterlini-Bréchot and her research group detected CTCs in all of the six SS patients being studied using the ISET (isolation by size of tumor cells) system and defining CTCs as either vimentin+CD45−CD34− or panCK+CD45-CD34−21. This evidence concerns the gene PTPRC and neoplasm.